Chemical pneumonitis natural history, complications, and prognosis: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
(One intermediate revision by one other user not shown) | |||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Approximately | Approximately 3 in 5 patients with chemical pneumonitis have clinical improvement with clearing of chest X ray. Approximately 1 in every 3rd patient shows a rapid improvement followed with a new progressive infiltrate that suggests a secondary superimposed bacterial infection or the development of [[ARDS]]. The least common course, but the one with the worst prognosis, is the development of fulminant disease resulting in acute death. | ||
==References== | ==References== | ||
Line 14: | Line 14: | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pneumonia]] | [[Category:Pneumonia]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] |
Latest revision as of 17:22, 18 September 2017
Chemical pneumonitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Chemical pneumonitis natural history, complications, and prognosis On the Web |
American Roentgen Ray Society Images of Chemical pneumonitis natural history, complications, and prognosis |
FDA on Chemical pneumonitis natural history, complications, and prognosis |
CDC onChemical pneumonitis natural history, complications, and prognosis |
Chemical pneumonitis natural history, complications, and prognosis in the news |
Blogs on Chemical pneumonitis natural history, complications, and prognosis |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Approximately 3 in 5 patients with chemical pneumonitis have clinical improvement with clearing of chest X ray. Approximately 1 in every 3rd patient shows a rapid improvement followed with a new progressive infiltrate that suggests a secondary superimposed bacterial infection or the development of ARDS. The least common course, but the one with the worst prognosis, is the development of fulminant disease resulting in acute death.